QQ客服 官方微博 反馈留言

	PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells
	Zhao, Xin-min; Pan, Shi-yun; Huang, Qi-ling; Lu, You-ni; Wu, Xiang-hua; Chang, Jian-hua; Liu, Zhe-Bin; Cai, Xu-Wei; Liu, Qi; Wang, Jia-lei
刊名	ONCOTARGET
	2016
卷号	7期号:31
关键词	NSCLC PA-MSHA apoptosis cell cycle EGFR
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3623303
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhao, Xin-min,Pan, Shi-yun,Huang, Qi-ling,et al. PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells[J]. ONCOTARGET,2016,7(31).
APA	Zhao, Xin-min.,Pan, Shi-yun.,Huang, Qi-ling.,Lu, You-ni.,Wu, Xiang-hua.,...&Fu, Xiao-Long.(2016).PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells.ONCOTARGET,7(31).
MLA	Zhao, Xin-min,et al."PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells".ONCOTARGET 7.31(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。